Moxonidine (BDF5895) hydrochloride is an orally active imidazoline type 1 receptor (I1-R) agonist. Moxonidine hydrochloride activates imidazoline I1 receptors and alpha2 adrenoceptors, affecting oxidized low-density lipoprotein uptake. Moxonidine hydrochloride reduces atherosclerotic lesions and lowers blood pressure. Moxonidine hydrochloride can be used in the study of hypertension, heart failure, and atherosclerosis[1][2][3][4][5][6][7].
Molekulargewicht:
278.14
Reinheit:
99.83
CAS Nummer:
[75536-04-8]
Formel:
C9H13Cl2N5O
Target-Kategorie:
Adrenergic Receptor,Imidazoline Receptor,LDLR
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten